Official announcements
Safety warnings
|
Blood & Tissue
|
05/08/2015
The Federal Office for Public Health Safety has been informed by the Italian authority that WNV NAT testing is being carried out in the provinces of Milano, Pavia, Lodi, Cremona and Parma and in the regions of Emilia and Modena.
Recall
|
Medicines
|
14/07/2015
The marketing authorization holder has informed its supplied customers in a letter dated 13.07.2015 that the above batch is being recalled as a precautionary measure because an outdated package insert was enclosed.
Safety warnings
|
messages in brief
|
01/07/2015
The European Medicines Agency (EMA) recommends new measures to ensure the safe and successful use of epinephrine auto-injectors. Introduction of new training material Patients should always carry two auto-injectors for safety. Measures at EU level…
Safety warnings
|
Blood & Tissue
|
01/07/2015
Documented autochthonous cases in French Gyuana, Gyuana.
messages in brief
|
30/06/2015
On May 12, 2015, the European Medicines Agency (EMA) announced that - in accordance with Article 27 of Regulation (EC) No. 726/2004 - starting on July 1, 2015, the search for suspected ADRs published in the scientific literature will be conducted by…
Recall
|
Medicines
|
30/06/2015
In a letter dated June 26, 2015, the marketing authorization holder informed its customers that ongoing stability tests have revealed values outside the specification for the degradation product ketolactam. The reason lies in a too long holding time…
messages in brief
|
23/06/2015
As of June 25, Austrian pharmacies will be allowed to sell over-the-counter medicines over the Internet - BMG and BASG launch educational campaign
Safety warnings
|
Blood & Tissue
|
23/06/2015
The Federal Ministry of Health takes the liberty of making the following observations.
Safety warnings
|
Blood & Tissue
|
03/06/2015
The Federal Office for Public Health Safety has been informed by the European Centre for Disease Prevention and Control (ECDC) of the first documented outbreak of ZIKA virus infection in Brazil and in some Pacific Islands (Vanuatu, Solomon Islands, New Caledonia).
Recall
|
Medicines
|
02/06/2015
The parallel distributor has informed its supplied customers in a letter dated June 2, 2015, that the affected batch A229473D is being recalled due to a falsification of the packaging. The marketing authorization holder "Gilead Sciences International…